who makes glp-1 Market Overview: Agonists and the Obesity Market | Blog GLP-1 Drug Manufacturers: Market Leaders
Description
Heres what we know so far
2023;10:e2300822
Groundbreaking clinical trials published in late 2023 and 2024 show that semaglutide, approved in 2019 for treating diabetes and in 2021 for weight management, also reduces rates of heart disease and kidney disease, and reduces tissue and systemic inflammation
So far, Ive only had small ketones once and have been fine otherwise
The top 10 off-target sites were predicted using The COSMID Tool ( following a previously established approach 20
She does not consider these drugs cure-alls and advises that everyone should go down this path cautiously
